Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections

Klinische Padiatrie

Volumn 211, Issue 2, 1999, Pages 65-69

  Mertens, Rolf ^a,b   Peschgens, Th ^a   Granzen, B ^a   Heimann, G ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

AT III, heparin; Disseminated intravascular coagulation; Fresh frozen plasma; Meningococcal disease

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN;

ANTICOAGULATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FLUID THERAPY; HEMOSTASIS; HEPARINIZATION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGOCOCCOSIS; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PRESCHOOL CHILD; PROTHROMBIN TIME; RESUSCITATION; SCHOOL CHILD;

EID: 0032940711     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043767     Document Type: Article

References (30)

1. 1 Algren, J. T., S. Lal, S. A. Cutliff, B. J. Richmann: Predictors of outcome in acute mcningococcal infection in Children. Crit. Care Med. 21 (1993) 447-452
2. 2 Beatty, D. W., C. R. Ryder, H. De v Heese: Complement abnormalities during an epidemic of group B meningococcal infection in children. Clin. Exp. Immunol. 40 (1992) 465-470
3. 3 Bermudez de la Vega, J., A. Gomez Caltado, M. Sobrino Toro, A. Aljeo Garcia -Mauricio, J. Romero Cachaza, J. Gonzales Hachero: Acute meningoccocal disease. Its prognostic assessment. An. Esp. Pediatr. 39 (1993) 214-218
4. 4 Blauhut, B., H. Kramar, H. Vinazzer, H. Bergmann: Substitution of antithrombin III in shock and DIC: A randomized study. Thromb. Res. 39 (1985) 81-89
5. 5 Brandtzaeg, P., G. B. Joo, B. Brusletto, P. Kierulf: Plasminogen activator inhibitor 1 and 2 alpha-2-antiplasmin, plasminogen and endotoxin levels in systemic meningococcal disease. Thromb. Res. 15 (1990) 271-278
6. 6 Brandtzaeg, P., R. Ovsteboo, P. Kierulf: Compartmentalization of lipopolysaccharide production correlates with clinical presention in meningococcal disease. J. Infect. Dis. 166 (1992) 650-652
7. 7 Corrigan, J. J., C. M. Jordan: Heparin therapy in septicemia with disseminated intravascular coagulation. Effect on mortality and on correction of hemostatic defects. N. Engl. J. Med. 3 (1970) 772-782
8. 8 Eckhof-Donovan, S., R. Kries, H. Stannigel, M. Günther, J. Holtzki, U. Göbel: Schwerer Protein-C-Mangel im Rahmen einer Menigokokkensepsis mit Purpura fulminans. Monatsschr. Kinderheilkd. 142 (1994) 580-584
9. 9 Feldstein, T. J., D. L. Uden, T. A. Larson: Cefotaxime for treatment of Gramnegative bacterial meningitis in infants and children. J. Pediatr. Dis. J. 6 (1987) 471-475
10. 10 Gerard, S. G., M. Moriau, A. Bachy, P. Malvaux, R. De Meyer: Meningoccocal purpura: report of 19 patients treated with heparin. J. Pediatr. 82 (1973) 780-786
11. 11 Glode, M. P., A. L. Smith: Meningococcal disease. In: Feigin RD, Cherry J, eds. Textbook of pediatric infectious diseases, vol 79. Philadelphia: Sauders, W.B. (1992) 918-925
12. 12 Havens, P. L., S. Jeffery, M. Michael: Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr. Infect. Dis. J. 8 (1989) 8-11
13. 13 Heydermann, R. S., N. J. Klein, G. I. Shennan, M. Levin: Deficiency of prostacyclin production in meningococcal shock. Arch. Dis. Child. 66 (1991) 1296-1299
14. 14 Horie, S., H. Ishii, M. Kazama: Heparin-like Glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent Prostacyclin production in human cells. Thrombosis Research 59 (1990) 895-904
15. 15 Jacobs, R. F., M. K. Sowell, M. M. Moss, D. M. Fiser: Septic shock in children: bacterial etiologies and temporal relationships . Pediatr. Infect. Dis. J. 9 (1990) 196-200
16. 16 Klein, N. J., R. S. Heydermann, M. Levin: Management of menigococcal infection. Brit. J. Hosp. Med. 50 (1993) 42-49
17. 17 Künzer, W.: Treatment of consumption coagulopathy. Monatsschr. Kinderheilkd. 136 (1988) 788-794
18. 18 Leclerc, F., F. Delepoulle, A. Martinot, F. J. Diependaele, D. Houque, V. Hue: Frequency of adrenal hemorrhage in fatal forms of purpura fulminans in children. Etiopathogenic and therapeutic considerations. Pediatrie 43 (1988) 545-550
19. 19 Leggiadro, R. J.: Prevalence of complement deficiencies in children with systemic meningococcal infections. Pediatr. Inf. Dis. 16 (1987) 75-77
20. 20 Lehner, P. J., K. A. Davies, M. J. Walport: Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release. Lancet 340 (1992) 1379-1381
21. 21 Manios, S. G., F. Kanakoudi, E. Maniati: Fulminant menigococcemia: heparin therapy and survival rate. Scand. J. Infect. Dis. 3 (1971) 127-133.
22. 22 Marzouk, O., P. J. Thomson, J. A. Sills, C. A. Hart, F. Harris: Features and out come in meningococcal disease presenting with maculopapular rash. Arch. Dis. Child. 66 (1991) 485-487
23. 23 Neveling, U., R. O. Kaschula: Fatal meningococcal disease in Chilhood;: an autopsy of 86 cases. Ann. trop. paediatr. 13 (1991) 147-152
24. 24 Nürnberger, W., A. Platonov, H. Stannigel, V. B. Beloborodov, I. Michelmann, R. Kries, S. Burdach, U. Göbel: Definition of new score for severity of generalizid Neisseria meningitidis infection. Eur. J. Pediatr. 154 (1995) 896-900
25. 25 Okajima, K., M. Uchiba, K. Murakami: Antithrombin replacement in DIC and MOF. In: Vincent, J. L., ed.: Yearbook of intensive care and emergency medicine, Vol 2 (1995) 457-464
26. 26 Peltola, H., M. Anttila, O. V. Renkonen: Randomised comparison of chloramphenical, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet 10 (1989) 1281-1287
27. 27 Resnick, S. D.: Toxic shock syndrome. Recent development in pathogenesis. J. Pediatr. 116 (1990) 321-327
28. 28 Tesoro, L. J., S. M. Selbst: Factors affecting outcome in meningococcal infection. AJDC 145 (1990) 218-220
29. 29 Vinazzer, H. A.: Antithrombin III in shock and disseminated intravascular coagulation. Clin. Appl. Thrombosis/Hemostasis 1 (1995) 62-65
30. 30 Waage, A., A. O. Aasen: Different role of cytokine mediators in septic shock related to menigoccocal disease surgery/polytrauma. Immunol. Rev. 127 (1992) 221-230